Skip to main content
. Author manuscript; available in PMC: 2010 Jan 7.
Published in final edited form as: Hypertension. 2008 Feb 19;51(4):884–890. doi: 10.1161/HYPERTENSIONAHA.107.100636

Figure 3.

Figure 3

Effect of chronic MC3/4R antagonism with SHU-9119 during α- and β-adrenergic receptor blockade with propranolol and terazosin on (A) mean arterial pressure and (B) heart rate in SHR (n=6) and WKY (n=5). The delta change in mean arterial pressure and heart rate represents the average of the last 5 days of SHU-9119 infusion. *P<0.05 vs α/β blockade alone.